Lead Singer Syndrome with Shane Told
Scott Stapp (Creed)
May 7, 2020
Scott Stapp, the legendary lead singer of Creed, opens up about his powerful journey from addiction to recovery, celebrating five years of sobriety. He shares insights on the pandemic's impact, fond memories of Creed's peak fame, and the amusing 'Creed bomb' phenomenon. Stapp discusses his latest solo single, 'Survivor,' and hints at the thrilling possibility of a Creed reunion, keeping fans eagerly guessing. With his charismatic presence, he reflects on resilience and the evolving music landscape.
34:50
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Scott Stapp attributes his return to music and success to perseverance, fan engagement, and the importance of storytelling in albums.
- The COVID-19 pandemic compelled Stapp to adapt creatively while emphasizing personal health and the significance of collective unity during challenging times.
Deep dives
Management of Ulcerative Colitis
Tromphia, also known as Gesalcomab, is a prescription medication designed to assist adults with moderately to severely active ulcerative colitis in managing their symptoms. Clinical studies indicate that many patients using Tromphia achieved clinical remission within a year, with a subset also experiencing endoscopic remission. It's crucial to note that results may vary among individuals, and the medication comes with potential risks, such as serious allergic reactions and increased vulnerability to infections. Before commencing treatment, a thorough health assessment, including checks for infections and tuberculosis, is recommended to mitigate these risks.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
